Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Neurosciences (Riyadh) ; 26(3): 295-299, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1299749

ABSTRACT

COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré.


Subject(s)
COVID-19/complications , COVID-19/diagnostic imaging , Miller Fisher Syndrome/diagnostic imaging , Miller Fisher Syndrome/etiology , Posterior Leukoencephalopathy Syndrome/diagnostic imaging , Posterior Leukoencephalopathy Syndrome/etiology , Child , Follow-Up Studies , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Miller Fisher Syndrome/drug therapy , Posterior Leukoencephalopathy Syndrome/drug therapy , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL